Lifestyle
- Regular physical activity
- Stress management techniques
- Adequate hydration
Plasma Renin Activity · PRA · Renin
Renin test quantifies the enzyme activity involved in the conversion of angiotensinogen to angiotensin I.
Values may vary based on posture, sodium intake, and medications.
Renin is an enzyme secreted by the kidneys that plays a crucial role in the renin-angiotensin-aldosterone system (RAAS), which regulates blood pressure and fluid balance. It catalyzes the conversion of angiotensinogen to angiotensin I, which is subsequently converted to angiotensin II, a potent vasoconstrictor. Clinically, renin levels are significant in diagnosing and managing conditions such as hypertension, heart failure, and certain kidney disorders. Elevated plasma renin activity is associated with increased cardiovascular morbidity and mortality. In the context of athletic performance and biohacking, understanding renin levels can provide insights into cardiovascular health and stress responses. However, renin levels can be influenced by various factors, including posture, sodium intake, and medications, making it important to consider these confounders when interpreting results. Time-of-day variations and fasting status may also affect renin measurements, necessitating standardized testing conditions for accurate assessment.
Klinische Bedeutung
Elevated renin levels can indicate conditions such as renovascular hypertension, heart failure, or primary hyperaldosteronism. Low renin levels may suggest conditions like primary aldosteronism or Cushing's syndrome.
Progressively rising renin levels may indicate worsening cardiovascular or renal conditions. Re-test in 4 weeks if outside optimal range.
Decreasing renin levels may suggest improvement in underlying conditions or response to treatment.
Re-test Interval
4 weeks if outside optimal range
Note:
Consult a healthcare provider before making significant lifestyle or dietary changes.
Renin levels can vary throughout the day; morning testing is often preferred.
Testing Frequency
Annually for individuals with hypertension or cardiovascular risk factors.
Correlated with
Current research suggests that reference ranges for plasma renin activity (PRA) remain poorly defined, with significant variability across laboratories and methods. Researchers have not yet established optimal targets for PRA in cardiovascular risk stratification or the impact of confounding factors such as medication and hydration status. Additionally, clinical questions remain unanswered regarding the prognostic value of renin levels in diverse populations and the long-term effects of RAAS-targeting therapies on renin dynamics.
154
Total Citations
3
Human/RCT
3.0
Avg. Influence
2024
Latest
This review highlighted the laboratory's role in screening for primary aldosteronism, focusing on the measurement of aldosterone and renin. Researchers noted that the lack of standardized methodologies has hindered diagnosis. New methods have improved the reliability of renin testing, which is crucial for accurate diagnosis.
This paper evaluated the role of renin as a biomarker for cardiovascular disease risk. Researchers found that elevated plasma renin activity is associated with increased morbidity and mortality in cardiovascular patients, highlighting the need for further investigation into its prognostic value.
Researchers discussed the importance of biomarkers, including renin, for diagnosing heart failure. They noted that renin is associated with neurohormonal pathways and emphasized the need for fast, portable biosensors to improve diagnostic processes. The review highlights the potential of biomarkers in enhancing heart failure management.
This case report described a patient with salt-losing nephropathy associated with voriconazole treatment. Researchers found elevated levels of plasma renin activity and antidiuretic hormone in the patient, indicating a complex interaction affecting fluid balance. Discontinuation of the drug and saline infusion improved the patient's condition.
This review summarized the clinical features and laboratory findings of juxtaglomerular cell tumors (JGCTs), which are linked to secondary hypertension. Researchers found that elevated plasma renin activity was commonly observed, with a median level significantly above normal. Most patients experienced normalization of blood pressure and renin levels post-surgery.
This study explored the development of a dual-functional polymer for detecting renin as a biomarker. Researchers found that the engineered polymer achieved high sensitivity in biomarker detection and demonstrated potential for disease therapy by effectively lowering blood pressure in animal models.
This review focused on plasma renin activity (PRA) as a screening tool for primary aldosteronism and hypertension. Researchers found significant inconsistencies in PRA measurement methods and emphasized the need for standardized procedures to improve diagnostic accuracy across laboratories.
This study evaluated the diagnostic accuracy of measuring aldosterone and renin using chemiluminescence for screening primary aldosteronism. Researchers found a strong correlation between methods for aldosterone measurement and significant diagnostic performance for the aldosterone-to-renin ratio, indicating its reliability for identifying patients with primary aldosteronism.
This study examined the changes in the renin-angiotensin system during septic shock in pigs. Researchers found significant increases in plasma renin activity and angiotensin levels, alongside a decrease in ACE activity and a shift toward the angiotensin-(1-7) axis. These findings suggest adaptive responses within the renin-angiotensin system that could inform sepsis management.
This review collated data on active renin and prorenin levels in pediatric populations. Researchers observed an age-dependent decline in plasma renin concentrations from newborns to adolescents. The study emphasizes the need for reliable assessment methods for renin levels in children, as current data is limited.
Research publications about Renin over time
7totalLog lab results, track trends and optimize your biomarkers over time.
This page is for informational and research purposes only. All information is based on published scientific literature and does not constitute medical advice, diagnosis, or treatment recommendations. Many substances listed may not be approved for human use and may be subject to drug regulation laws (e.g., AMG in Germany, FDA in the US). PepStack does not encourage the use of any substance on humans. Always consult a qualified healthcare professional before making any health-related decisions. Use of this information is entirely at your own risk. PepStack assumes no liability for the accuracy, completeness, or timeliness of the content provided. Full disclaimer